5634 related articles for article (PubMed ID: 3930068)
21. A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro.
Hoover DL; Finbloom DS; Crawford RM; Nacy CA; Gilbreath M; Meltzer MS
J Immunol; 1986 Feb; 136(4):1329-33. PubMed ID: 3080522
[TBL] [Abstract][Full Text] [Related]
22. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
[TBL] [Abstract][Full Text] [Related]
23. Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.
Svedersky LP; Benton CV; Berger WH; Rinderknecht E; Harkins RN; Palladino MA
J Exp Med; 1984 Mar; 159(3):812-27. PubMed ID: 6421982
[TBL] [Abstract][Full Text] [Related]
24. The role of monocyte cytotoxic factor (CF) in cytostasis mediated by IFN-gamma-activated monocytes.
Kildahl-Andersen O; Nissen-Meyer J
Immunology; 1985 Oct; 56(2):367-72. PubMed ID: 3932193
[TBL] [Abstract][Full Text] [Related]
25. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
Murray HW; Rubin BY; Carriero S; Acosta AM
J Immunol; 1984 Oct; 133(4):2250-4. PubMed ID: 6432909
[TBL] [Abstract][Full Text] [Related]
26. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
Nathan CF; Murray HW; Wiebe ME; Rubin BY
J Exp Med; 1983 Sep; 158(3):670-89. PubMed ID: 6411853
[TBL] [Abstract][Full Text] [Related]
27. Human monocytes in a long-term culture with interleukin-2 show high tumoricidal activity against various tumor cells.
Higashi N; Nishimura Y; Higuchi M; Osawa T
J Immunother (1991); 1991 Aug; 10(4):247-55. PubMed ID: 1718408
[TBL] [Abstract][Full Text] [Related]
28. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
Hamann U; Krammer PH
Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of monocyte-mediated tumoricidal activity by multiple interferon-alpha species.
Webb DS; Zur Nedden D; Miller DM; Zoon KC; Gerrard TL
Cell Immunol; 1989 Nov; 124(1):158-67. PubMed ID: 2529978
[TBL] [Abstract][Full Text] [Related]
30. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor.
Grabstein KH; Urdal DL; Tushinski RJ; Mochizuki DY; Price VL; Cantrell MA; Gillis S; Conlon PJ
Science; 1986 Apr; 232(4749):506-8. PubMed ID: 3083507
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
Schreiber RD; Hicks LJ; Celada A; Buchmeier NA; Gray PW
J Immunol; 1985 Mar; 134(3):1609-18. PubMed ID: 2578513
[TBL] [Abstract][Full Text] [Related]
32. Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937.
Harris PE; Ralph P; Litcofsky P; Moore MA
Cancer Res; 1985 Jan; 45(1):9-13. PubMed ID: 2981161
[TBL] [Abstract][Full Text] [Related]
33. Biological and biochemical characterization of macrophage activating factor (MAF) in murine lymphocytes: physiocochemical similarity of MAF to gamma interferon (IFN-gamma).
Fukazawa Y; Kagaya K; Miura H; Shinoda T; Natori K; Yamazaki S
Microbiol Immunol; 1984; 28(6):691-702. PubMed ID: 6434908
[TBL] [Abstract][Full Text] [Related]
34. Human macrophage-activating factors for cytotoxicity. II. Synergism of two factors produced by a human T-cell hybridoma that induce the cytotoxicity of human monocytes.
Higuchi M; Sugimoto M; Kobayashi Y; Osawa T
Microbiol Immunol; 1987; 31(5):481-90. PubMed ID: 3116372
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.
Fischer DG; Golightly MG; Koren HS
J Immunol; 1983 Mar; 130(3):1220-5. PubMed ID: 6401781
[TBL] [Abstract][Full Text] [Related]
36. MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.
Thurman GB; Braude IA; Gray PW; Oldham RK; Stevenson HC
J Immunol; 1985 Jan; 134(1):305-9. PubMed ID: 3917277
[TBL] [Abstract][Full Text] [Related]
37. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
Saiki I; Sone S; Fogler WE; Kleinerman ES; Lopez-Berestein G; Fidler IJ
Cancer Res; 1985 Dec; 45(12 Pt 1):6188-93. PubMed ID: 3933823
[TBL] [Abstract][Full Text] [Related]
38. Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma.
Hoover DL; Nacy CA; Meltzer MS
Cell Immunol; 1985 Sep; 94(2):500-11. PubMed ID: 3928173
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.
Spitalny GL; Havell EA
J Exp Med; 1984 May; 159(5):1560-5. PubMed ID: 6425450
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives.
Sone S; Lopez-Berestein G; Fidler IJ
Cancer Immunol Immunother; 1986; 21(2):93-9. PubMed ID: 3081250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
